Immunogenicity of different brands of human insulin and rapid-acting insulin analogs in insulin-naïve children with type 1 diabetes

Pediatric Diabetes

Volumn 12, Issue 2, 2011, Pages 78-84

  Mianowska, B ^a   Szadkowska, A ^a   Pietrzak, I ^a   Zmyslowska A ^a   Wegner, O ^a   Tomczonek, J ^a   Bodalski, J ^a   Mlynarski W ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Children; Insulin analogs; Insulin antibodies; Insulin therapy; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN ANTIBODY; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN LISPRO; ISOPHANE INSULIN;

ADOLESCENT; ANTIBODY DETECTION; ARTICLE; CHILD; DRUG INDUSTRY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DOSAGE FORMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFANT; INSULIN; INSULIN ANTIBODIES; MALE;

EID: 79952001754     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2010.00659.x     Document Type: Article

References (27)

1. Fineberg SE, Kawabata TT, Finco-Kent D, Fountaine RJ, Finch GL, Krasner AS. Immunological responses to exogenous insulin. Endocr Rev 2007: 28: 625-652.
2. La Merie Business Intelligence. (Accessed 2009).
3. Schernthaner G, Borkenstein M, Fink M, Mayr WR, Menzel J, Schober E. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals. Diabetes Care 1983: 6: 43-48.
4. Davis SN, Thompson CJ, Peak M, Brown MD, Alberti KGMM. Effects of human insulin on insulin binding antibody production in nondiabetic subjects. Diabetes Care 1992: 15: 124-126.
5. Fineberg SE, Galloway JA, Fineberg NS, Rathbun MJ, Hufferd S. Immunogenicity of recombinant DNA human insulin. Diabetologia 1983: 25: 465-469.
6. Richter B, Neises G. 'Human' insulin versus animal insulin in people with diabetes mellitus. Cochrane Database Syst Rev 2005, 1. Art. No.: CD003816. DOI: 10.1002/14651858.CD003816.pub2.
7. Fineberg NS, Fineberg SE, Anderson JH, Birkett MA, Gibson RG, Hufferd S. Immunologic effect of insulin lispro [Lys(B28), Pro(B29) human insulin] in IDDM and NIDDM patients previously treated with insulin. Diabetes 1996: 45: 1750-1754.
8. Fineberg SE, Huang J, Brunelle R, Gulliya KS, Anderson JH. Effect of long-term exposure to insulin lispro on the induction of antibody response in patients with type 1 or type 2 diabetes. Diabetes Care 2003: 26: 89-96.
9. Lindholm A, Jensen LB, Home PD, Raskin P, Boehm BO, Rastam J. Immune response to insulin aspart and biphasic insulin aspart in people with type 1 and type 2 diabetes. Diabetes Care 2002: 25: 876-882.
10. Holmberg H, Mersebach H, Kanc K, Ludviggson J. Antibody response to insulin in children and adolescents with newly diagnosed type 1 diabetes. Diabet Med 2008: 25: 792-797.
11. Grammer LC, Chen PY, Patterson R. Evaluation and management of insulin allergy. J Allergy Clin Immunol 1983: 71: 250-254.
12. Raile K, Noelle V, Landgraf R, Schwartz HP. Insulin antibodies are associated with lipoatrophy but also with lipohypertrophy in children and adolescents with type 1 diabetes. Exp Clin Endocrinol Diabetes 2001: 109: 393-396.
13. Davidson JK, DeBra DW. Immunologic insulin resistance. Diabetes 1978: 27: 307-18.
14. Lahtela JT, Knip M, Paul R, Antonen J, Salmi J. Severe antibody-mediated human insulin resistance: successful treatment with the insulin analog lispro. Diabetes Care 1997: 20: 71-73.
15. Francis AJ, Hanning I, Alberti KG. The influence of insulin antibody levels on the plasma profiles and action of subcutaneously injected human and bovine short acting insulins. Diabetologia 1985: 28: 330-334.
16. Van Haeften TW, Heiling VJ, Gerich JE. Adverse effects of insulin antibodies on postprandial plasma glucose and insulin profiles in diabetic patients without immune insulin resistance: implications for intensive insulin regimens. Diabetes 1987: 36: 305-309.
17. Tran MP, Larsen JL, Duckworth WC et al. Anti-insulin antibodies are a cause of hypoglycemia following pancreas transplantation. Diabetes Care 1994: 17: 988-993.
18. Kure M, Katsura Y, Kosano H et al. A trial to assess the amount of insulin antibodies in diabetic patients by surface plasmon resonance. Intern Med 2005: 44: 100-106.
19. Mianowska B, Perenc M, Heinrich A, Bodalski J. Severe hypoglycemia and insulin antibodies levels in children and adolescents with type 1 diabetes. Endokrynologia, Diabetologia i Choroby Przemiany Materii. Wieku Rozwojowego 2003: 9: 29-34.
20. Alberti KGMM, Zimmet PZ, for the WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus. Report of a WHO Consultation. 1999: 1-59.
21. Balsells M, Corcoy R, Mauricio MD et al. Insulin antibody response to short course of human insulin therapy in women with gestational diabetes. Diabetes Care 1997: 20: 1172-1175.
22. Arslanian SA, Becker DJ, Rabin B et al. Correlates of insulin antibodies in newly diagnosed children with insulin-dependent diabetes before insulin therapy. Diabetes 1985: 34: 926-930.
23. Schloot NC, Roep BO, Wegmann D et al. Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects. Diabetologia 1997: 40: 564-572.
24. Fineberg NS, Fineberg SE, Galloway J. Does age at initiation of insulin therapy determine who will develop an immune response? Diabetes 1992: 41 (Suppl. 1): 191A (Abstract).
25. Dahl-Jorgensen K, Torjesen P, Hanssen KF, Sandvik L, Aagenaes O. Increase in insulin antibodies during continuous subcutaneous insulin infusion and multiple-injection therapy in contrast to conventional treatment. Diabetes 1987: 36: 1-5.
26. De Beaufort CE, Houtzagers CM, Bruining GJ et al. Continuous subcutaneous insulin infusion (CSII) versus conventional injection therapy in newly diagnosed diabetic children: two-year follow-up of a randomized, prospective trial. Diabet Med 1989: 6: 766-71.
27. Castéra V, Dutour-Meyer A, Koeppel M, Petitjean C, Darmon P. Systemic allergy to human insulin and its rapid and long acting analogs: successful treatment by continuous subcutaneous insulin lispro infusion. Diabetes Metab 2005: 31: 391-400.